Lab
Sault Tribe of Chippewa Indians
Sault Tribe of Chippewa Indians was paid $515K by Medicaid between Jan 2018 and Sep 2024, across 45 billing codes. Its largest line is 82306, Vitamin D; 25 hydroxy, includes fraction(s), if performed — 18% of everything it billed.
33Billing provider infoSAULT TRIBE OF CHIPPEWA INDIANS
SAULT SAINTE MARIE, MI 49783
SAULT SAINTE MARIE, MI 49783
33aNPI1750434395assigned 01/18/2007
33bProvider typeClinical Medical Laboratory
28Total paid$515K
24GClaims42,631
24DCodes billed45
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Michigan
Rank by total paid#57 of 108
Median peer was paid$588K
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,177 | $59K | |
| 2019 | 4,865 | $59K | |
| 2020 | 4,908 | $61K | |
| 2021 | 7,008 | $88K | |
| 2022 | 7,608 | $89K | |
| 2023 | 8,224 | $99K | |
| 2024incomplete | 4,841 | $59K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 18% | 3,603 | 3,585 | $90K |
| 84443 | Thyroid stimulating hormone (TSH) | 12% | 4,351 | 4,300 | $59K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 9.5% | 304 | 304 | $49K |
| 80053 | Comprehensive metabolic panel | 9.3% | 5,296 | 5,216 | $48K |
| 80061 | Lipid panel | 8.1% | 3,677 | 3,666 | $41K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.0% | 6,361 | 6,251 | $41K |
| 83036 | Hemoglobin; glycosylated (A1C) | 6.9% | 4,331 | 4,313 | $35K |
| 84439 | 3.6% | 2,447 | 2,423 | $19K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.5% | 367 | 360 | $18K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.9% | 504 | 489 | $15K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.8% | 489 | 475 | $15K |
| 82607 | 2.8% | 1,159 | 1,156 | $14K |
33 more codes
| 82746 | 2.3% | 997 | $12K | |
| 83735 | 1.7% | 1,629 | $9K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 181 | $8K |
| 81001 | <1% | 1,930 | $5K | |
| 87088 | <1% | 617 | $4K | |
| 84466 | <1% | 403 | $4K | |
| 87081 | <1% | 660 | $4K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 178 | $4K |
| 83540 | <1% | 696 | $4K | |
| 83655 | <1% | 322 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 381 | $3K |
| 82728 | <1% | 189 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 196 | $1K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 51 | $1K |
| 83970 | <1% | 29 | $957.79 | |
| 86703 | <1% | 73 | $893.24 | |
| 82570 | <1% | 213 | $795.61 | |
| 86803 | <1% | 68 | $794.69 | |
| 87070 | <1% | 106 | $747.69 | |
| 87077 | <1% | 94 | $703.88 | |
| 81025 | <1% | 70 | $454.68 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 14 | $448.00 |
| 84146 | <1% | 24 | $384.96 | |
| 87186 | <1% | 25 | $173.05 | |
| 82180 | <1% | 16 | $131.04 | |
| 82043 | <1% | 27 | $124.28 | |
| 82310 | <1% | 32 | $123.23 | |
| 80076 | <1% | 16 | $112.80 | |
| 85652 | <1% | 27 | $69.24 | |
| 82248 | <1% | 16 | $66.56 | |
| 85027 | <1% | 12 | $64.20 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 437 | $2.70 |
| 83519 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCULFA, BONNIE (HEALTH DIRECTOR)
Parent organizationSAULT TRIBE OF CHIPPEWA INDIANS
| Provider | Location | Paid |
|---|---|---|
| Sault Tribe of Chippewa Indians | Sault Sainte Marie, MI | $18.55M |
| Sault Tribe of Chippewa Indians | Sault Sainte Marie, MI | $5.93M |
| Sault Tribe of Chippewa Indians | Sault Sainte Marie, MI | $1.67M |
| Sault Tribe of Chippewa Indians | Sault Sainte Marie, MI | $1.46M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.